SARTORIUS (UNSP.ADS)/1/5
Research SARTORIUS (UNSP.ADS)/1/5 (SRT0) on Bullrun: market cap EUR 16.78B, P/E 85.3, dividend yield 0.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSRT0
- ExchangeF
- CountryGermany
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 16.78B
- P/E85.3
- Dividend yield0.3%
- Financial periodQ2 2026
- RevenueEUR 911.80M
- Net incomeEUR 65.90M
- Free cash flowEUR 92.10M
- Gross margin47.5%
Valuation Snapshot
latest market cap is EUR 16.78B; P/E is 85.3; dividend yield is 0.3%.
Peer valuation comparison
Latest P/E is 85.26x versus a Healthcare sector median of 24.67x (245.7% above).
Latest dividend yield is 0.3% versus a Healthcare sector median of 1.84% (83.7% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-06 | EUR 16.78B | 85.3 | 0.3% | 0.14 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.14 EUR, yield 0.3%.
About SARTORIUS (UNSP.ADS)/1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SARTORIUS (UNSP.ADS)/1/5's market cap?
SARTORIUS (UNSP.ADS)/1/5's market capitalization is EUR 16.78B.
What is SARTORIUS (UNSP.ADS)/1/5's P/E ratio?
SARTORIUS (UNSP.ADS)/1/5's price-to-earnings (P/E) ratio is 85.3.
Does SARTORIUS (UNSP.ADS)/1/5 pay a dividend?
SARTORIUS (UNSP.ADS)/1/5 has a dividend yield of 0.3%.
What does SARTORIUS (UNSP.ADS)/1/5 do?
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid.